MGLMX
Price
$16.63
Change
+$0.05 (+0.30%)
Updated
Dec 3 closing price
Net Assets
2.2B
RREAX
Price
$29.45
Change
+$0.04 (+0.14%)
Updated
Dec 3 closing price
Net Assets
386.41M
Interact to see
Advertisement

MGLMX vs RREAX

Header iconMGLMX vs RREAX Comparison
Open Charts MGLMX vs RREAXBanner chart's image
MFS Global Real Estate R4
Price$16.63
Change+$0.05 (+0.30%)
VolumeN/A
Net Assets2.2B
Russell Inv Global Real Estate Secs A
Price$29.45
Change+$0.04 (+0.14%)
VolumeN/A
Net Assets386.41M
MGLMX vs RREAX Comparison Chart in %
View a ticker or compare two or three
VS
MGLMX vs. RREAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLMX is a Buy and RREAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLMX has more cash in the bank: 2.2B vs. RREAX (386M). RREAX pays higher dividends than MGLMX: RREAX (3.09) vs MGLMX (2.48). MGLMX was incepted earlier than RREAX: MGLMX (11 years) vs RREAX (19 years). RREAX (1.42) is less costly to investors than MGLMX (0.95). RREAX is a more actively managed with annual turnover of: 70.00 vs. MGLMX (48.00). MGLMX (0) and RREAX (0) have matching initial minimum investment requirements. RREAX annual gain was more profitable for investors over the last year : 1.89 vs. MGLMX (-3.00). RREAX return over 5 years is better than : 7.20 vs. MGLMX (1.78).
MGLMXRREAXMGLMX / RREAX
Total Expense Ratio0.941.3470%
Annual Report Gross Expense Ratio0.951.4267%
Fund Existence11 years19 years-
Gain YTD3.5498.64641%
Front LoadN/A6%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets2.2B386M569%
Annual Yield % from dividends2.483.0980%
Returns for 1 year-3.001.89-159%
Returns for 3 years2.9916.9318%
Returns for 5 years1.787.2025%
Returns for 10 years24.744.84511%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CPOCX19.270.47
+2.50%
Morgan Stanley Insight L
DTCAX21.060.04
+0.19%
BNY Mellon Sust US Equity A
PCAQX92.620.09
+0.10%
Principal Capital Appreciation R5
IPHYF1.99N/A
N/A
Innate Pharma
PRPRF0.02N/A
N/A
Prairie Provident Resources Inc